PARENTERAL DRUG (India) Today

Equity ratings for PARENTERAL DRUG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of September 2019 and ending today, the 31st of July 2021. Click here to learn more.
PARENTERAL DRUG cannot be verified against its exchange. Apparently, PARENTERAL DRUG is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

PARENTERAL DRUG Stock Profile

Parenteral Drugs Limited operates as a healthcare company in India and internationally.. The public information regarding PARENTERAL DRUG's current market price is not available at this time.
PARENTERAL DRUG is not yet fully synchronised with the market data
PARENTERAL DRUG has some characteristics of a very speculative penny stock
PARENTERAL DRUG has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 6.88 B in total debt with debt to equity ratio (D/E) of 2.11, implying the company greatly relies on financing operations through barrowing. PARENTERAL DRUG has a current ratio of 0.53, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported the revenue of 2.6 B. Net Loss for the year was (1.17 B) with profit before overhead, payroll, taxes, and interest of 766 M.
Legal NamePARENTERAL DRUG
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of PARENTERAL DRUG's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
PARENTERAL DRUG (PDPL) is traded on National Stock Exchange of India in India and employs 4 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 99.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PARENTERAL DRUG's market, we take the total number of its shares issued and multiply it by PARENTERAL DRUG's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. PARENTERAL DRUG has 29.81 M outstanding shares.
Check PARENTERAL DRUG Probability Of Bankruptcy

PARENTERAL Stock Against Markets

Picking the right benchmark for PARENTERAL DRUG stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in PARENTERAL DRUG stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for PARENTERAL DRUG is critical whether you are bullish or bearish towards PARENTERAL DRUG at a given time.
PARENTERAL DRUG cannot be verified against its exchange. Apparently, PARENTERAL DRUG is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PARENTERAL DRUG stock to make a market-neutral strategy. Peer analysis of PARENTERAL DRUG could also be used in its relative valuation, which is a method of valuing PARENTERAL DRUG by comparing valuation metrics with similar companies.
Check out Your Equity Center. Note that the PARENTERAL DRUG information on this page should be used as a complementary analysis to other PARENTERAL DRUG's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for PARENTERAL Stock

When running PARENTERAL DRUG price analysis, check to measure PARENTERAL DRUG's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PARENTERAL DRUG is operating at the current time. Most of PARENTERAL DRUG's value examination focuses on studying past and present price action to predict the probability of PARENTERAL DRUG's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move PARENTERAL DRUG's price. Additionally, you may evaluate how the addition of PARENTERAL DRUG to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go